Abstract
Background
Epidemiological studies of gastroesophageal reflux disease (GERD) in Japan vary in design. This systematic review examines the prevalence of GERD in Japan, distinguishing between study methodologies, and reports on changes over time and factors potentially associated with GERD.
Methods
PubMed and Embase searches identified studies reporting the prevalence of GERD in the general population, primary care patients, and individuals undergoing routine health checks.
Results
Of the twenty eligible studies, half excluded individuals taking acid-suppressive medication, so these studies would have been likely to have underestimated the prevalence by 2–3%. Nine studies reported the prevalence of at least weekly reflux symptoms (the definition closest to the Montreal definition): in seven studies this was 6.5–9.5%, but in two studies that included individuals who underwent upper gastrointestinal endoscopy the prevalence was 19.0 and 21.8%. Eight studies used symptom scores: prevalence estimates ranged from 10.2 to 29.0% in five studies using the Carlsson–Dent self-administered questionnaire (QUEST), and from 27.0 to 37.6% in three studies using the frequency scale for the symptoms of GERD. Prevalence estimates were 15.1–24.3% in three studies that reported the presence of reflux symptoms of undefined frequency. Six studies reported the prevalence of reflux esophagitis as 4.9–8.2%. Changes in prevalence over time and factors associated with reflux symptoms were inconsistent.
Conclusions
Few studies have reported the prevalence of GERD in Japan using standardized criteria. Thus, prevalence estimates vary substantially, reflecting differences in study populations and GERD definitions. However, seven studies reported that the prevalence of at least weekly symptoms was 6.5–9.5%, a finding which approaches that reported in Western populations (10–20%).
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- 95% CI:
-
95% confidence interval
- FSSG:
-
Frequency scale for the symptoms of GERD
- GERD:
-
Gastroesophageal reflux disease
- LA:
-
Los Angeles
- OR:
-
Odds ratio
- QUEST:
-
Carlsson–Dent self-administered questionnaire
References
Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–7.
Wong BCY, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol. 2006;4:398–407.
Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD)—a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20.
Okamoto E. Japanese Public Health Association Report. In: Tatara K, editor. 136th meeting of the American Public Health Association, October 25–29, 2008, San Diego.
Fujiwara Y, Higuchi K, Watanabe Y, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26–9.
Watanabe Y, Fujiwara Y, Shiba M, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol. 2003;38:807–11.
Yamagishi H, Koike T, Ohara S, et al. Prevalence of gastroesophageal reflux symptoms in a large unselected general population in Japan. World J Gastroenterol. 2008;14:1358–64.
Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518–34.
Fujimoto K. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther. 2004;20(Suppl 8):S5–8.
Shimatani T, Hirokawa S, Hamai K et al. H. pylori infection is not involved in the pathogenesis of erosive and non-erosive reflux disease in a young population: studies from a health check-up program of 678 consecutive Japanese subjects in their 20 s. Gastroenterology 2008;134(Suppl 1):A594.
Kusano M, Fujimoto K. Surveillance of non-consultant GERD using a GERD-specific questionnaire (FSSG) by internet interview in a Japanese population. Gastroenterology 2009;136(Suppl 1):A292.
Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999;231:S20–8.
Suganuma N, Shigedo Y, Adachi H, et al. Association of gastroesophageal reflux disease with weight gain and apnea, and their disturbance on sleep. Psychiatry Clin Neurosci. 2001;55:255–6.
Watanabe T, Urita Y, Sugimoto M, Miki K. Gastroesophageal reflux disease symptoms are more common in general practice in Japan. World J Gastroenterol. 2007;13:4219–23.
Kubota E, Tanida S, Sasaki M, et al. Contribution of Helicobacter pylori infection and obesity on heartburn in a Japanese population. J Clin Biochem Nutr. 2006;39:168–73.
Kato K, Kodama T, Fujita S et al. Epidemiology of gastroesophageal reflux disease: a questionnaire-based survey of heartburn symptoms. In: Matsuo Y, Kasuya Y, Muto T, Tsuchiya M, editors. 15th Symposium on the regulation and disturbances of gastrointestinal function, vol 15. Tokyo: Excerpta Medica; 1996. p. 69–75.
Hirakawa K, Adachi K, Amano K, et al. Prevalence of non-ulcer dyspepsia in the Japanese population. J Gastroenterol Hepatol. 1999;14:1083–7.
Kawanishi M. Will symptomatic gastroesophageal reflux disease develop into reflux esophagitis? J Gastroenterol. 2006;41:440–3.
Yagi N, Arai M, Fujimoto S. Importance of lifestyle advice in the management of endoscopically negative gastroesophageal reflux disease patients in Japan. Shokakika 2006;43:194–201 (in Japanese).
Miyamoto M, Haruma K, Kuwabara M, et al. High incidence of newly developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study. J Gastroenterol Hepatol. 2008;23:393–7.
Mishima I, Adachi K, Arima N, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol. 2005;40:1005–9.
Azumi T, Adachi K, Arima N, et al. Five-year follow-up study of patients with reflux symptoms and reflux esophagitis in annual medical check-up field. Intern Med. 2008;47:691–6.
Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023–9.
Sudou H, Tanaka Y, Kurai A et al. The usefulness of QUEST questionnaire and PPI test in the assessment of GERD in clinical practice. Nippon Rinsho Naika Ikai Zasshi 2007;22:71–5 (in Japanese).
Funatsu K, Tomai K, Kurihara K, et al. A clinical study on erosive and non-erosive gastroesophageal reflux disease in health check-up subjects. Ningen Dock 2008;22:811–7 (in Japanese).
Kusano M, Shimoyama Y, Sugimoto S, et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD. J Gastroenterol. 2004;39:888–91.
Yamagishi H, Koike T, Ohara S, et al. Clinical characteristics of gastroesophageal reflux disease in Japan. Hepatogastroenterology. 2009;56:1032–4.
Kase H, Hattori Y, Sato N, Banba N, Kasai K. Symptoms of gastroesophageal reflux in diabetes patients. Diabetes Res Clin Pract. 2008;79:e6–7.
Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.
Miwa H, Yokoyama T, Hori K, et al. Interobserver agreement in endoscopic evaluation of reflux esophagitis using a modified Los Angeles classification incorporating grades N and M: a validation study in a cohort of Japanese endoscopists. Dis Esophagus. 2008;21:355–63.
Numans ME, de Wit NJ. Reflux symptoms in general practice: diagnostic evaluation of the Carlsson–Dent gastro-oesophageal reflux disease questionnaire. Aliment Pharmacol Ther. 2003;17:1049–55.
Spechler SJ, Jain SK, Tendler DA, Parker RA. Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2002;16:1795–800.
Manabe N, Haruma K, Hata J, Kamada T, Kusunoki H. Differences in recognition of heartburn symptoms between Japanese patients with gastroesophageal reflux, physicians, nurses, and healthy lay subjects. Scand J Gastroenterol. 2008;43:398–402.
Danjo A, Yamaguchi K, Fujimoto K, et al. Comparison of endoscopic findings with symptom assessment systems (FSSG and QUEST) for gastroesophageal reflux disease in Japanese centres. J Gastroenterol Hepatol. 2009;24:633–8.
Nagano K, Kubo M, Goto M et al. The diagnosis of GERD: a study of a questionnaire (QUEST) for patients complaining of upper gastrointestinal symptoms. J New Rem Clin. 1998;47:841–51 (in Japanese).
Haque M, Wyeth JW, Stace NH, Talley NJ, Green R. Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study. N Z Med J. 2000;113:178–81.
Malfertheiner P. Current concepts in dyspepsia: a world perspective. Eur J Gastroenterol Hepatol. 1999;11(Suppl 1):S25–9.
Ruigómez A, García Rodríguez LA, Wallander MA, et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther. 2004;20:751–60.
Ruigómez A, García Rodríguez LA, Wallander MA, et al. Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice. Chest. 2005;128:85–93.
He J, Ma X, Zhao Y, et al. Gastroesophageal reflux disease prevalence and associated factors: the Systematic Investigation of gastrointestinal diseases in China (SILC) epidemiological study. Gastroenterology 2009;136(Suppl 1):S35.
Fukuda Y, Nakamura K, Takano T. Wide range of socioeconomic factors associated with mortality among cities in Japan. Health Promot Int. 2004;19:177–87.
Fujiwara Y, Takahashi S, Arakawa T, et al. A 2008 questionnaire-based survey of gastroesophageal reflux disease and related diseases by physicians in East Asian countries. Digestion. 2009;80:119–28.
Hongo M. Completion report GERD Guideline Workshop Report 2002. Therapeutic Res. 2003;24:830–4.
Ciba T, Kinoshita Y, Fujimoto K et al. Gastroesophageal reflux disease guidelines gastroenterology Jso, editor. Tokyo: Nankodo Publishing; 2009.
Tijssen JG. Representativeness and response rates from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999;231:S15–9.
Enck P, Dubois D, Marquis P. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol Suppl. 1999;231:S48–54.
Acknowledgments
We thank Dr Nesta Hughes of Oxford PharmaGenesis™ Ltd, who provided medical writing support funded by AstraZeneca R&D Mölndal, Sweden. This study was funded in full by AstraZeneca R&D Mölndal, Sweden.
Conflict of interest
Yoshikazu Kinoshita has worked as an advisor for AstraZeneca and Eisai Pharmaceuticals, and is a member of speaker boards for Takeda and AstraZeneca. Kyoichi Adachi has no personal or financial conflicts of interest to disclose. Michio Hongo has worked as an advisor for AstraZeneca, Astellas, Eisai, Sucampo, Takeda, and Zeria Pharmaceuticals. Ken Haruma has no personal or financial conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kinoshita, Y., Adachi, K., Hongo, M. et al. Systematic review of the epidemiology of gastroesophageal reflux disease in Japan. J Gastroenterol 46, 1092–1103 (2011). https://doi.org/10.1007/s00535-011-0429-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-011-0429-3